A nucleoside-modified mRNA (modRNA) influenza vaccine showed greater protection against influenza-like illness compared to a standard inactivated vaccine in adults. 2. The modRNA vaccine triggered ...
This is a preview. Log in through your library . Abstract Combined vaccine formulations targeting not only hemagglutinin but also other influenza virus antigens could form the basis for a universal ...
A quadrivalent nucleoside-modified messenger RNA influenza vaccine met superiority criteria compared with a licensed inactivated vaccine.
An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.
Researchers found that the relative efficacy of the modRNA vaccine was 34.5% against influenza-like illness compared with the control vaccine, on the basis of 57 and 87 cases in the modRNA and control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback